P1‐533: DO BIOMARKERS DIFFERENTIATE COGNITIVE PROFILES IN MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE?

  1. Campos-Magdaleno, Maria 1
  2. Lojo-Seoane, Cristina 1
  3. Lindín, Mónica 1
  4. Santamaría-Cadavid, María 3
  5. Domínguez-Vivero, Clara 3
  6. Mallo, Sabela C. 1
  7. Facal, David 1
  8. Spuch, Carlos 2
  9. Pereiro, Arturo X. 1
  1. 1 University of Santiago de Compostela Santiago de Compostela Spain
  2. 2 Galicia Sur Health Research Institute CIBERSAM Vigo Spain
  3. 3 University Hospital of Santiago de Compostela Santiago de Compostela Spain
Mostrar afiliaciones +
Revista:
Alzheimer's & Dementia

ISSN: 1552-5260,  1552-5279

Año de publicación: 2018

Volumen: 14

Número: 7S_Part_9

Tipo: Artículo

DOI: 10.1016/J.JALZ.2018.06.544 GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Alzheimer's & Dementia

Resumen

Relationships between cerebrospinal fluid (CSF) markers of Mild cognitive impairment (MCI) due to Alzheimer's disease (AD) and subjective and cognitive markers are not yet completely established. Identification of cognitive changes or complaints related to the presence of CSF markers in the preclinical states of AD (Dubois et al., 2014) is important for an early diagnosis and intervention. The aim of this preliminary study was to determine differences in cognitive performance between individuals with MCI due to AD with varying levels of certainty according to CSF markers.